Evidence map›Paper›PMID 39081632›Full record

Trial reportJournal of immunology research2024

Breastfeeding and Neonatal Age Influence Neutrophil-Driven Ontogeny of Blood Cell Populations in the First Week of Human Life.

Sebastiano Montante, Rym Ben-Othman, Nelly Amenyogbe, Asimenia Angelidou, Anita van den Biggelaar, Bing Cai, Yixuan Chen, Alansana Darboe, Joann Diray-Arce, Rebecca Ford and 19 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of immunology research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03246230 (Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03246230 nacompletednot on this map

Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity

TypeinterventionalSponsorBoston Children's HospitalRan2017 to 2022Enrolled911ConditionsNewborn Vaccine ImmunogenicityArmsHepatitis B vaccine (HBV), Bacillus Calmette-Guérin (BCG)
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Sebastiano MontanteBC Cancer Agency, 675 West 10th Avenue, Vancouver V5Z 1G1, BC, Canada.ORCID https://orcid.org/0000-0002-6717-8706
Rym Ben-OthmanTelethon Kids Institute Perth Children's Hospital, 15 Hospital Avenue, Nedlands 6009, WA, Australia.ORCID https://orcid.org/0000-0002-7245-6854
Nelly AmenyogbeTelethon Kids Institute Perth Children's Hospital, 15 Hospital Avenue, Nedlands 6009, WA, Australia.ORCID https://orcid.org/0000-0002-7817-1534
Asimenia AngelidouPrecision Vaccines Program Department of Pediatrics Boston Children's Hospital, Boston, MA, USA.
Anita van den BiggelaarWesfarmers Centre of Vaccines and Infectious Diseases Telethon Kids Institute University of Western Australia Perth, 15 Hospital Avenue, Nedlands, WA 6009, Australia.
Bing CaiDepartment of Pediatrics BC Children's Hospital University of British Columbia, 4480 Oak Street, Vancouver V6H 3V4, BC, Canada.
Yixuan ChenBC Cancer Agency, 675 West 10th Avenue, Vancouver V5Z 1G1, BC, Canada.
Alansana DarboeVaccines and Immunity Theme Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Banjul P.O. Box 273, Gambia.
Joann Diray-ArcePrecision Vaccines Program Department of Pediatrics Boston Children's Hospital, Boston, MA, USA.
Rebecca FordPapua New Guinea Institute of Medical Research, Homate Street, 441, Goroka, Eastern Highlands Province, Papua New Guinea.
Olubukola IdokoDepartment of Clinical Research Faculty of Infectious and Tropical Diseases London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Amy LeeDepartment of Molecular Biology and Biochemistry Simon Fraser University, 8888 University Dr. Burnaby V5A1S6, Burnaby, British Columbia, Canada.
Mandy LoTelethon Kids Institute Perth Children's Hospital, 15 Hospital Avenue, Nedlands 6009, WA, Australia.
Kerry McEnaneyPrecision Vaccines Program Department of Pediatrics Boston Children's Hospital, Boston, MA, USA.
Mehrnoush MalekBC Cancer Agency, 675 West 10th Avenue, Vancouver V5Z 1G1, BC, Canada.
David MartinoWal-yan Respiratory Research Centre Telethon Kids Institute University of Western Australia, Perth, Australia.
Geraldine MasiriaPapua New Guinea Institute of Medical Research, Homate Street, 441, Goroka, Eastern Highlands Province, Papua New Guinea.
Oludare A OdumadePrecision Vaccines Program Department of Pediatrics Boston Children's Hospital, Boston, MA, USA.ORCID https://orcid.org/0000-0002-8630-8510
William PomatPapua New Guinea Institute of Medical Research, Homate Street, 441, Goroka, Eastern Highlands Province, Papua New Guinea.
Casey ShannonPROOF Centre of Excellence, 10th floor, 1190 Hornby Street, Vancouver V6Z 2K5, British Columbia, Canada.
Kinga SmolenPrecision Vaccines Program Department of Pediatrics Boston Children's Hospital, Boston, MA, USA.
The Epic ConsortiumNIH, National Institute of Health, Bethesda, USA.
Al OzonoffPrecision Vaccines Program Department of Pediatrics Boston Children's Hospital, Boston, MA, USA.
Peter RichmondTelethon Kids Institute Perth Children's Hospital, 15 Hospital Avenue, Nedlands 6009, WA, Australia.
Scott TebbuttPROOF Centre of Excellence, 10th floor, 1190 Hornby Street, Vancouver V6Z 2K5, British Columbia, Canada.
Ofer LevyPrecision Vaccines Program Department of Pediatrics Boston Children's Hospital, Boston, MA, USA.ORCID https://orcid.org/0000-0002-5859-1945
Beate KampmannVaccines and Immunity Theme Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Banjul P.O. Box 273, Gambia.
Ryan BrinkmanBC Cancer Agency, 675 West 10th Avenue, Vancouver V5Z 1G1, BC, Canada.ORCID https://orcid.org/0000-0002-9765-2990
Tobias KollmannTelethon Kids Institute Perth Children's Hospital, 15 Hospital Avenue, Nedlands 6009, WA, Australia.ORCID https://orcid.org/0000-0003-2403-9762

Funding

Transcriptomics to define biomarkers of neonatal vaccine immunogenicityU19AI118608 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2017 to 2021
$24.7M
Proteomics and Metabolomics Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthmaU19AI168643 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI OFER LEVY · 2022 to 2026
$10.0M
Immunometabolic signatures of BCG-induced neonatal trained immunityK08AI168487 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Asimenia Angelidou · 2023 to 2026
$704k
NIAID NIH HHS K08 AI168487NIAID NIH HHS U19 AI118608NIAID NIH HHS U19 AI168643
6 · The paper itself

Abstract

The first few days of life are characterized by rapid external and internal changes that require substantial immune system adaptations. Despite growing evidence of the impact of this period on lifelong immune health, this period remains largely uncharted. To identify factors that may impact the trajectory of immune development, we conducted stringently standardized, high-throughput phenotyping of peripheral white blood cell (WBC) populations from 796 newborns across two distinct cohorts (The Gambia, West Africa; Papua New Guinea, Melanesia) in the framework of a Human Immunology Project Consortium (HIPC) study. Samples were collected twice from each newborn during the first week of life, first at Day of Life 0 (at birth) and then subsequently at Day of Life 1, 3, or 7 depending on the randomization group the newborn belongs to. The subsequent analysis was conducted at an unprecedented level of detail using flow cytometry and an unbiased automated gating algorithm. The results showed that WBC composition in peripheral blood changes along patterns highly conserved across populations and environments. Changes across days of life were most pronounced in the innate myeloid compartment. Breastfeeding, and at a smaller scale neonatal vaccination, were associated with changes in peripheral blood neutrophil and monocyte cell counts. Our results suggest a common trajectory of immune development in newborns and possible association with timing of breastfeeding initiation, which may contribute to immune-mediated protection from infection in early life. These data begin to outline a specific window of opportunity for interventions that could deliberately direct WBC composition, and with that, immune trajectory and thus ontogeny in early life. This trial is registered with NCT03246230.

Indexed as

Breast FeedingNeutrophilsAge FactorsFemaleFlow CytometryGambiaHumansInfant, NewbornLeukocyte CountMaleMonocytesPapua New GuineaVaccination

Identifiers

PMID39081632
PMCPMC11288693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.